5-carboxyfluorescein diacetate has been researched along with indinavir sulfate in 2 studies
Studies (5-carboxyfluorescein diacetate) | Trials (5-carboxyfluorescein diacetate) | Recent Studies (post-2010) (5-carboxyfluorescein diacetate) | Studies (indinavir sulfate) | Trials (indinavir sulfate) | Recent Studies (post-2010) (indinavir sulfate) |
---|---|---|---|---|---|
41 | 0 | 13 | 1,834 | 328 | 146 |
Protein | Taxonomy | 5-carboxyfluorescein diacetate (IC50) | indinavir sulfate (IC50) |
---|---|---|---|
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (BRU ISOLATE) | 0.0004 | |
Gag polyprotein | HIV-1 M:B_MN | 0.02 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.2 | |
Gag-Pol polyprotein | Human immunodeficiency virus type 1 (NEW YORK-5 ISOLATE) | 0.0261 | |
Substance-K receptor | Homo sapiens (human) | 5.101 | |
Thromboxane-A synthase | Homo sapiens (human) | 1.851 | |
Protease | Human immunodeficiency virus 1 | 0.0349 | |
Multidrug and toxin extrusion protein 2 | Homo sapiens (human) | 7.8 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 3.8 | |
Protease | Human immunodeficiency virus 1 | 0.0044 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
2 other study(ies) available for 5-carboxyfluorescein diacetate and indinavir sulfate
Article | Year |
---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |